Ilumya
Payments companies reported to CMS as associated with Ilumya. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ilumya, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ilumya
These are the largest totals companies reported as associated with Ilumya. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Steven Feldman | Winston Salem, NC | Dermatology | $375,118.24 |
| Cory Rubin | Waterford, MI | Clinical & Laboratory Dermatological Immunology | $345,909.57 |
| Omar Noor | Somerset, NJ | $267,016.23 | |
| James Wharton | Lexington, KY | Dermatology | $251,480.86 |
| Amylynne Frankel | Spartanburg, SC | Dermatology | $247,177.24 |
| David Nelsen | Janesville, WI | Dermatology | $183,341.03 |
| Robert Greenberg | Livermore, CA | Dermatology | $149,750.51 |
| Scott Gottlieb | Exton, PA | Dermatology | $149,172.76 |
| Laertes Manuelidis | Fort Myers, FL | Procedural Dermatology | $140,256.49 |
| John Koo | San Francisco, CA | Psychiatry | $135,189.06 |
Prescribed Ilumya?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.